vimarsana.com

Page 2 - Securely Automating Real Time Transfer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

/PRNewswire/ Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software.

United statesOphir shahafIddo pelegVincent lepreuxYonalink saaIsabelle pelveHead of communicationsVp business developmentCompany saaTechnology brings new levels of speedDebiopharm internationalShadar groupEuropean unionPrnewswire debiopharm innovation fundHealth venturesDebiopharm innovation fund

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

/PRNewswire/ Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software.

United statesOphir shahafIddo pelegVincent lepreuxYonalink saaIsabelle pelveHead of communicationsVp business developmentCompany saaTechnology brings new levels of speedDebiopharm internationalShadar groupEuropean unionPrnewswire debiopharm innovation fundHealth venturesDebiopharm innovation fund

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

SaaS Platform Provides Missing Link in Clinical Trial Data Collection, Securely Automating Real-Time Transfer of Up-to-Date Patient Data Directly

United statesOphir shahafIddo pelegVincent lepreuxYonalink saaIsabelle pelveHead of communicationsVp business developmentCompany saaTechnology brings new levels of speedShadar groupEuropean unionPrnewswire debiopharm innovation fundHealth venturesDebiopharm innovation fundSaas platform provides missing link

Debiopharm leads $6M round for YonaLink to Scale Global Growth and Fuel Expansion of Platform Designed to Stream Clinical Trial Data

/PRNewswire/ Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and YonaLink, a clinical trial software.

United statesOphir shahafIddo pelegVincent lepreuxYonalink saaIsabelle pelveHead of communicationsVp business developmentCompany saaTechnology brings new levels of speedDebiopharm internationalShadar groupEuropean unionPrnewswire debiopharm innovation fundHealth venturesDebiopharm innovation fund

vimarsana © 2020. All Rights Reserved.